Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention

被引：9
作者：
Afshar A.E. [1 ]
Parikh P.B. [1 ]
机构：
[1] Division of Cardiovascular Medicine, Department of Medicine, State University of New York at Stony Brook, Stony Brook, 11794, NY
来源：
Current Treatment Options in Cardiovascular Medicine | 2018年 / 20卷 / 4期
关键词：
Cardiac catheterization; Contrast-induced acute kidney injury; Contrast-induced nephropathy; Radiation injury;
D O I：
10.1007/s11936-018-0621-3
中图分类号：
学科分类号：
摘要：
Purpose of review: In this review, we provide a summary of the recently published literature on various methods of preventing contrast-induced acute kidney injury (CI-AKI) and radiation-related injuries associated with cardiac catheterization and percutaneous coronary intervention (PCI). Recent findings: The overall reported incidence of CI-AKI is declining, primarily due to adaptation of a standardized definition for CI-AKI as well as implementation of pre-procedural protocols to prevent or decrease the risk of CI-AKI. The implementation of increasing awareness and establishing radiation protection culture has been shown to be effective measures in reducing radiation exposure. Summary: Coronary angiography and PCI are valuable diagnostic and therapeutic tools in cardiovascular medicine. Accurate imaging of the coronary arteries in cardiac catheterization is dependent on the use of intravascular injection of iodinated contrast media and fluoroscopic imaging. Patients undergoing diagnostic and interventional cardiac catheterization may be exposed to a substantial amount of contrast media and ionizing radiation. Administration of contrast media is correlated with increased risk of CI-AKI, and exposure to radiation is known to be associated with a spectrum of acute and chronic tissue injuries. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 78 条
  • [1] Kellum J.A., Lameire N., Group KAGW K.A.G.W., Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1), Crit Care, 17, 1, (2013)
  • [2] Mamoulakis C., Tsarouhas K., Fragkiadoulaki I., Heretis I., Wilks M.F., Spandidos D.A., Tsitsimpikou C., Tsatsakis A., Contrast-induced nephropathy: basic concepts, pathophysiological implications and prevention strategies, Pharmacol Ther, 180, pp. 99-112, (2017)
  • [3] Tsai T.T., Patel U.D., Chang T.I., Kennedy K.F., Masoudi F.A., Matheny M.E., Kosiborod M., Amin A.P., Messenger J.C., Rumsfeld J.S., Spertus J.A., Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry, JACC Cardiovasc Interv, 7, 1, pp. 1-9, (2014)
  • [4] Wilhelm-Leen E., Montez-Rath M.E., Chertow G., Estimating the risk of radiocontrast-associated nephropathy, J Am Soc Nephrol, 28, 2, pp. 653-659, (2017)
  • [5] Newhouse J.H., Kho D., Rao Q.A., Starren J., Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity, AJR Am J Roentgenol, 191, 2, pp. 376-382, (2008)
  • [6] McCullough P.A., Choi J.P., Feghali G.A., Schussler J.M., Stoler R.M., Vallabahn R.C., Et al., Contrast-induced acute kidney injury, J Am Coll Cardiol, 68, 13, pp. 1465-1473, (2016)
  • [7] Persson P.B., Hansell P., Liss P., Pathophysiology of contrast medium-induced nephropathy, Kidney Int, 68, 1, pp. 14-22, (2005)
  • [8] Guitterez N.V., Diaz A., Timmis G.C., O'Neill W.W., Stevens M.A., Sandberg K.R., Et al., Determinants of serum creatinine trajectory in acute contrast nephropathy, J Interv Cardiol, 15, 5, pp. 349-354, (2002)
  • [9] Sharma P.V., Babu S.C., Shah P.M., Nassoura Z.E., Changing patterns of atheroembolism, Cardiovasc Surg, 4, 5, pp. 573-579, (1996)
  • [10] Azzalini L., Garcia-Moll X., On contrast-induced acute kidney injury, risk prediction, and the future of predictive model development, Can J Cardiol, 33, 6, pp. 711-713, (2017)
12345678